Bank of New York Mellon
KURA icon

Bank of New York Mellon’s Kura Oncology KURA Stock Holding History

Bank of New York Mellon’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Buy
257,767
+3,442
+1% +$32.5K ﹤0.01% 2753
2026
Q1 		$2.07M Sell
254,325
-4,102
-2% -$35.2K ﹤0.01% 2793
2025
Q4 		$2.69M Buy
258,427
+3,187
+1% +$33.4K ﹤0.01% 2674
2025
Q3 		$2.26M Buy
255,240
+16,733
+7% +$119K ﹤0.01% 2734
2025
Q2 		$1.38M Buy
238,507
+37,695
+19% +$231K ﹤0.01% 2938
2025
Q1 		$1.33M Sell
200,812
-2,129
-1% -$16.6K ﹤0.01% 2896
2024
Q4 		$1.77M Sell
202,941
-2,737
-1% -$39.4K ﹤0.01% 2811
2024
Q3 		$4.02M Sell
205,678
-50,219
-20% -$1.02M ﹤0.01% 2401
2024
Q2 		$5.27M Buy
255,897
+11,212
+5% +$230K ﹤0.01% 2325
2024
Q1 		$5.22M Sell
244,685
-16,104
-6% -$313K ﹤0.01% 2309
2023
Q4 		$3.75M Sell
260,789
-955
-0.4% -$9.39K ﹤0.01% 2512
2023
Q3 		$2.39M Buy
261,744
+25,677
+11% +$261K ﹤0.01% 2707
2023
Q2 		$2.5M Buy
236,067
+10,516
+5% +$124K ﹤0.01% 2716
2023
Q1 		$2.76M Sell
225,551
-5,114
-2% -$63.8K ﹤0.01% 2615
2022
Q4 		$2.86M Buy
230,665
+2,004
+0.9% +$29.1K ﹤0.01% 2650
2022
Q3 		$3.12M Buy
228,661
+21,821
+11% +$337K ﹤0.01% 2560
2022
Q2 		$3.79M Sell
206,840
-24,813
-11% -$357K ﹤0.01% 2468
2022
Q1 		$3.72M Buy
231,653
+812
+0.4% +$11.7K ﹤0.01% 2576
2021
Q4 		$3.23M Sell
230,841
-24,230
-9% -$393K ﹤0.01% 2703
2021
Q3 		$4.78M Buy
255,071
+36,351
+17% +$685K ﹤0.01% 2512
2021
Q2 		$4.56M Sell
218,720
-79,622
-27% -$1.98M ﹤0.01% 2541
2021
Q1 		$8.43M Buy
298,342
+12,746
+4% +$403K ﹤0.01% 2188
2020
Q4 		$9.33M Buy
285,596
+43,007
+18% +$1.51M ﹤0.01% 2042
2020
Q3 		$7.43M Buy
242,589
+35,696
+17% +$788K ﹤0.01% 2009
2020
Q2 		$3.37M Buy
206,893
+57,065
+38% +$823K ﹤0.01% 2411
2020
Q1 		$1.49M Buy
149,828
+4,919
+3% +$56.3K ﹤0.01% 2704
2019
Q4 		$1.99M Buy
144,909
+3,821
+3% +$56.6K ﹤0.01% 2820
2019
Q3 		$2.14M Buy
141,088
+19,436
+16% +$346K ﹤0.01% 2722
2019
Q2 		$2.4M Sell
121,652
-414
-0.3% -$6.87K ﹤0.01% 2711
2019
Q1 		$2.02M Buy
122,066
+593
+0.5% +$9.14K ﹤0.01% 2771
2018
Q4 		$1.71M Buy
121,473
+9,218
+8% +$122K ﹤0.01% 2809
2018
Q3 		$1.97M Buy
112,255
+9,884
+10% +$189K ﹤0.01% 2842
2018
Q2 		$1.86M Buy
102,371
+19,072
+23% +$323K ﹤0.01% 2887
2018
Q1 		$1.56M Buy
83,299
+16,363
+24% +$319K ﹤0.01% 2955
2017
Q4 		$1.02M Buy
66,936
+7,655
+13% +$113K ﹤0.01% 3234
2017
Q3 		$886K Buy
59,281
+28,031
+90% +$263K ﹤0.01% 3295
2017
Q2 		$291K Buy
+31,250
New +$284K ﹤0.01% 3828

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
SGA
Sector Gamma AS Oslo, Norway $461M AUM 33.26% 1-Year Est. Return

Bank of New York Mellon's KURA Position: Q2 2026 in Review

Bank of New York Mellon increased its Kura Oncology (KURA) stake by 1.4% in Q2 2026, buying an estimated $32.5K and bringing the position to 257,767 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2753.

Bank of New York Mellon first reported a position in KURA in Q2 2017 and has held it in 37 quarters since. The position peaked at $9.33M in Q4 2020. 105 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Bank of New York Mellon held 257,767 shares of Kura Oncology worth $2.83M as of Q2 2026.
  • Bank of New York Mellon bought 3,442 Kura Oncology shares in Q2 2026, an estimated $32.5K.
  • Kura Oncology made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2753 holding.
  • Bank of New York Mellon first reported a position in Kura Oncology in Q2 2017 and has held it in 37 quarters since.
  • Bank of New York Mellon's Kura Oncology position peaked at $9.33M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.